Roche’s Drug Candidate Meets Main Goals in Late-Stage Breast Cancer Study

Dow Jones – HealthMonday, September 22, 2025 at 6:08:00 AM
PositiveHealth
Roche’s Drug Candidate Meets Main Goals in Late-Stage Breast Cancer Study
Roche has announced promising results from its late-stage study of giredestrant, a drug candidate for advanced breast cancer. The combination of giredestrant and everolimus has shown a significant improvement in progression-free survival for patients, marking a potential breakthrough in treatment options. This is important as it could lead to better outcomes for those battling this challenging disease.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Latest from Health
Roche’s Drug Candidate Meets Main Goals in Late-Stage Breast Cancer Study
PositiveHealth
Roche has announced promising results from its late-stage study of giredestrant, a drug candidate for advanced breast cancer. The combination of giredestrant and everolimus has shown a significant improvement in progression-free survival for patients, marking a potential breakthrough in treatment options. This is important as it could lead to better outcomes for those battling this challenging disease.
Costco recalls poke sold under Kirkland Signature brand over possible listeria contamination
NegativeHealth
Costco has issued a recall for over 3,300 pounds of Ahi Tuna Wasabi Poke sold under its Kirkland Signature brand due to potential listeria contamination linked to the green onions used in the product. This recall is significant as listeria can pose serious health risks, particularly to vulnerable populations. Consumers who purchased this product are advised to check their refrigerators and return it to the store for a refund, ensuring their safety and well-being.
Heard on the Street: Signs of a turnaround are emerging for Novo Nordisk—the maker of Ozempic and Wegovy
PositiveHealth
Novo Nordisk is showing promising signs of recovery, especially with a new weight-loss pill on the way and the FDA indicating a stricter approach to compounded knockoffs. This is significant as it could enhance the company's market position and boost confidence among investors and consumers alike.
The FDA is cracking down on direct-to-consumer pharmaceutical ads
PositiveHealth
The FDA's recent crackdown on direct-to-consumer pharmaceutical ads marks a significant shift in how these advertisements are regulated. This increased scrutiny aims to ensure that consumers receive accurate information about medications, potentially leading to better health outcomes. By holding companies accountable for misleading claims, the FDA is taking a proactive stance in protecting public health.
This Geriatrics Training Program Escaped the Ax. For Now.
PositiveHealth
The Trump administration has decided to restore funding to a crucial geriatrics training program that equips healthcare professionals with the skills needed to care for aging Americans. This decision is significant as it ensures that the workforce is better prepared to meet the needs of an increasingly older population, which is vital for improving health outcomes and quality of life for seniors.
A Maternity Ward in Chad Reaches Its Breaking Point as U.S. Aid Dries Up
NegativeHealth
The humanitarian crisis stemming from the war in Sudan has reached alarming levels in Chad, where a maternity ward is struggling to cope as U.S. aid dwindles. This situation is dire for pregnant women, whose lives are increasingly at risk without the necessary support. The plight of refugees, like Taiba Baraka, highlights the urgent need for international assistance to prevent further loss of life and ensure safe childbirth in these challenging conditions.